ATE501744T1 - Einfaches verfahren zur transplantation von injizierbaren chondrozyten für eine autologe chondrozyten-transplantation - Google Patents

Einfaches verfahren zur transplantation von injizierbaren chondrozyten für eine autologe chondrozyten-transplantation

Info

Publication number: ATE501744T1
Authority: AT; Austria
Prior art keywords: mixing; chondrocyte; transplanting; injectable; syringe
Prior art date: 2005-07-20

Application number

AT05809011T

Other languages

English (en)

Inventor

Chang-Kwon Ko

Eun-Young Lee

Jeong-Yong Choi

Jae-Deog Jang

Cheong-Ho Chang

Pyoung-Min Kim

Original Assignee

Sewon Cellontech Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-07-20

Filing date

2005-09-23

Publication date

2011-04-15

2005-09-23 Application filed by Sewon Cellontech Co Ltd filed Critical Sewon Cellontech Co Ltd

2011-04-15 Application granted granted Critical

2011-04-15 Publication of ATE501744T1 publication Critical patent/ATE501744T1/de

Links

210000001612 chondrocyte Anatomy 0.000 title abstract 7
238000000034 method Methods 0.000 title abstract 2
238000002054 transplantation Methods 0.000 title abstract 2
210000000845 cartilage Anatomy 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 3
239000008176 lyophilized powder Substances 0.000 abstract 2
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 abstract 1
102000008186 Collagen Human genes 0.000 abstract 1
108010035532 Collagen Proteins 0.000 abstract 1
102000009123 Fibrin Human genes 0.000 abstract 1
108010073385 Fibrin Proteins 0.000 abstract 1
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 abstract 1
108010049003 Fibrinogen Proteins 0.000 abstract 1
102000008946 Fibrinogen Human genes 0.000 abstract 1
108090000190 Thrombin Proteins 0.000 abstract 1
229920001436 collagen Polymers 0.000 abstract 1
229960005188 collagen Drugs 0.000 abstract 1
229950003499 fibrin Drugs 0.000 abstract 1
229940012952 fibrinogen Drugs 0.000 abstract 1
229920002674 hyaluronan Polymers 0.000 abstract 1
229960003160 hyaluronic acid Drugs 0.000 abstract 1
239000002075 main ingredient Substances 0.000 abstract 1
239000000725 suspension Substances 0.000 abstract 1
229960004072 thrombin Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/363—Fibrinogen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/3852—Cartilage, e.g. meniscus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Zoology (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
Immunology (AREA)
Oral & Maxillofacial Surgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Transplantation (AREA)
Cell Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
Botany (AREA)
Hematology (AREA)
Vascular Medicine (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Inorganic Chemistry (AREA)
Materials For Medical Uses (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Prostheses (AREA)

AT05809011T 2005-07-20 2005-09-23 Einfaches verfahren zur transplantation von injizierbaren chondrozyten für eine autologe chondrozyten-transplantation ATE501744T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
KR1020050066026A KR100774089B1 (ko)	2005-07-20	2005-07-20	주입형 연골세포치료제의 이식방법
PCT/KR2005/003147 WO2007011094A1 (en)	2005-07-20	2005-09-23	Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantation

Publications (1)

Publication Number	Publication Date
ATE501744T1 true ATE501744T1 (de)	2011-04-15

Family

ID=37668959

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05809011T ATE501744T1 (de)	2005-07-20	2005-09-23	Einfaches verfahren zur transplantation von injizierbaren chondrozyten für eine autologe chondrozyten-transplantation

Country Status (18)

Country	Link
US (1)	US20090254065A1 (de)
EP (1)	EP1912661B1 (de)
JP (1)	JP2009501605A (de)
KR (1)	KR100774089B1 (de)
CN (1)	CN101247815A (de)
AT (1)	ATE501744T1 (de)
BR (1)	BRPI0520520A2 (de)
CY (1)	CY1111563T1 (de)
DE (1)	DE602005027004D1 (de)
DK (1)	DK1912661T3 (de)
ES (1)	ES2361420T3 (de)
HR (1)	HRP20110321T1 (de)
MX (1)	MX2008000787A (de)
PL (1)	PL1912661T3 (de)
PT (1)	PT1912661E (de)
RS (1)	RS51951B (de)
SI (1)	SI1912661T1 (de)
WO (1)	WO2007011094A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101114773B1 (ko) *	2009-10-23	2012-03-05	세원셀론텍(주)	연골조직 수복용 조성물의 제조방법
CN101716382B (zh) *	2009-12-02	2015-07-15	浙江大学	一种质粒dna/纤维蛋白凝胶/聚合物三元复合支架的制备方法
KR20160129108A (ko) *	2011-04-15	2016-11-08	가톨릭대학교 산학협력단	결합조직 재생용 조성물 및 결합조직을 재생하는 방법
KR101279812B1 (ko) *	2012-05-16	2013-06-28	세원셀론텍(주)	연골조직 수복용 조성물의 제조방법
CN105255814B (zh) *	2015-10-27	2016-09-21	上海科医联创生物科技有限公司	一种用于微骨折手术的软骨诱导基质的制备方法
CN106581772B (zh) *	2016-12-02	2020-02-18	四川大学华西医院	携带G-CSF缓释系统的Fibrin-HA水凝胶及其制备方法和用途
KR20190092059A (ko) *	2018-01-30	2019-08-07	가톨릭대학교 산학협력단	연골세포, 피브리노겐, 콜라겐 또는 트롬빈을 포함하는 관절경하 수술을 위한 연골 재생용 조성물
CN113440726B (zh) *	2021-01-26	2025-07-15	南方科技大学	一种非手性磁控微型支架机器人及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5842477A (en) *	1996-02-21	1998-12-01	Advanced Tissue Sciences, Inc.	Method for repairing cartilage
US5866165A (en) *	1997-01-15	1999-02-02	Orquest, Inc.	Collagen-polysaccharide matrix for bone and cartilage repair
US6886568B2 (en) *	1998-04-08	2005-05-03	The Johns Hopkins University	Method for fabricating cell-containing implants
KR20010082172A (ko) *	1998-08-14	2001-08-29	추후제출	연골세포 이식을 위한 방법, 기구 및 물질
IL153490A0 (en) *	2000-06-29	2003-07-06	Biosyntech Canada Inc	Composition and method for the repair and regeneration of cartilage and other tissues
US7931687B2 (en) *	2002-05-13	2011-04-26	Articular Engineering, Llc	Tissue engineered osteochondral implant
US7316822B2 (en) *	2003-11-26	2008-01-08	Ethicon, Inc.	Conformable tissue repair implant capable of injection delivery
KR100531922B1 (ko)	2003-12-23	2005-11-29	주식회사 셀론텍	연골치료제 조성물 및 그 사용방법

2005
- 2005-07-20 KR KR1020050066026A patent/KR100774089B1/ko not_active Expired - Lifetime
- 2005-09-23 WO PCT/KR2005/003147 patent/WO2007011094A1/en not_active Ceased
- 2005-09-23 EP EP05809011A patent/EP1912661B1/de not_active Expired - Lifetime
- 2005-09-23 JP JP2008522686A patent/JP2009501605A/ja active Pending
- 2005-09-23 BR BRPI0520520-4A patent/BRPI0520520A2/pt not_active Application Discontinuation
- 2005-09-23 DK DK05809011.9T patent/DK1912661T3/da active
- 2005-09-23 HR HR20110321T patent/HRP20110321T1/hr unknown
- 2005-09-23 ES ES05809011T patent/ES2361420T3/es not_active Expired - Lifetime
- 2005-09-23 RS RS20110196A patent/RS51951B/sr unknown
- 2005-09-23 PL PL05809011T patent/PL1912661T3/pl unknown
- 2005-09-23 SI SI200531297T patent/SI1912661T1/sl unknown
- 2005-09-23 US US11/988,924 patent/US20090254065A1/en not_active Abandoned
- 2005-09-23 CN CNA2005800510893A patent/CN101247815A/zh active Pending
- 2005-09-23 DE DE602005027004T patent/DE602005027004D1/de not_active Expired - Lifetime
- 2005-09-23 MX MX2008000787A patent/MX2008000787A/es active IP Right Grant
- 2005-09-23 AT AT05809011T patent/ATE501744T1/de active
- 2005-09-23 PT PT05809011T patent/PT1912661E/pt unknown
2011
- 2011-06-15 CY CY20111100569T patent/CY1111563T1/el unknown

Also Published As

Publication number	Publication date
DK1912661T3 (da)	2011-06-06
CY1111563T1 (el)	2015-10-07
DE602005027004D1 (de)	2011-04-28
BRPI0520520A2 (pt)	2009-05-12
PL1912661T3 (pl)	2011-08-31
EP1912661B1 (de)	2011-03-16
CN101247815A (zh)	2008-08-20
MX2008000787A (es)	2008-04-08
PT1912661E (pt)	2011-05-25
HRP20110321T1 (hr)	2011-06-30
JP2009501605A (ja)	2009-01-22
ES2361420T3 (es)	2011-06-16
KR100774089B1 (ko)	2007-11-06
KR20070010990A (ko)	2007-01-24
RS51951B (sr)	2012-02-29
EP1912661A1 (de)	2008-04-23
WO2007011094A1 (en)	2007-01-25
US20090254065A1 (en)	2009-10-08
SI1912661T1 (sl)	2011-07-29
EP1912661A4 (de)	2009-09-09

Legal Events

Date

Code

Title

Description

2011-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1912661

Country of ref document: EP

Publication	Publication Date	Title
CY1111563T1 (el)	2015-10-07	Απλη μεθοδος μεταμοσχευσης ενεσιμων χονδροκυτταρων για αυτολογο μεταμοσχευση χονδροκυτταρων
Fennema et al.	2018	Ectopic bone formation by aggregated mesenchymal stem cells from bone marrow and adipose tissue: a comparative study
Mifune et al.	2013	The effect of platelet-rich plasma on the regenerative therapy of muscle derived stem cells for articular cartilage repair
Nguyen et al.	2011	Engineering articular cartilage with spatially-varying matrix composition and mechanical properties from a single stem cell population using a multi-layered hydrogel
US8497121B2 (en)	2013-07-30	Method of obtaining viable small tissue particles and use for tissue repair
Wise et al.	2014	Comparison of uncultured marrow mononuclear cells and culture-expanded mesenchymal stem cells in 3D collagen-chitosan microbeads for orthopedic tissue engineering
Smith et al.	2014	The current ‘state of play’of regenerative medicine in horses: what the horse can tell the human
EP2491961A1 (de)	2012-08-29	Zusammensetzung zur induzierung von geweberegeneration mittel aktivierung von thrombozytenreichem plasma und herstellungsverfahren dafür
Park et al.	2009	In vitro and in vivo chondrogenesis of rabbit bone marrow–derived stromal cells in fibrin matrix mixed with growth factor loaded in nanoparticles
US20130287753A1 (en)	2013-10-31	Compositions and Methods for Cartilage Repair
Lalegül-Ülker et al.	2019	Encapsulation of bone marrow-MSCs in PRP-derived fibrin microbeads and preliminary evaluation in a volumetric muscle loss injury rat model: modular muscle tissue engineering
RU2010142988A (ru)	2012-05-10	Способ и композиция для регенерации тканей с помощью стволовых или костномозговых клеток
Gamer et al.	2017	Identification and characterization of adult mouse meniscus stem/progenitor cells
Harris et al.	2017	Biofabrication of soft tissue templates for engineering the bone–ligament interface
Sassoon et al.	2012	Skeletal muscle and bone marrow derived stromal cells: a comparison of tenocyte differentiation capabilities
Shanbhag et al.	2021	Spheroid coculture of human gingiva-derived progenitor cells with endothelial cells in modified platelet lysate hydrogels
de Albornoz et al.	2018	Cell therapies in tendon, ligament, and musculoskeletal system repair
Gui et al.	2015	Isolation and characterization of meniscus derived stem cells from rabbit as a possible treatment for damaged meniscus
Fülber et al.	2021	Chondrogenic potential of mesenchymal stem cells from horses using a magnetic 3D cell culture system
MY144022A (en)	2011-07-29	Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantation
Li et al.	2025	Response of a tenomodulin-positive subpopulation of human adipose-derived stem cells to decellularized tendon slices
JP6801993B2 (ja)	2020-12-16	軟骨細胞注入キット
Desai et al.	0	Novel In Situ Forming Hydrogels for Cartilage Tissue Engineering
Zelenka	2012	The Effect of Bmp-13 on the Chondroinduction of Mesenchymal Stem Cells
Aziz	2016	Regenerative Techniques in Periodontology.